Abiopharma

🔍 ANGEL STEPHEN F (Executive)

Company: CSX CORP (CSX)

Report Date: 2026-04-01

Detailed Transactions and Holdings:

• Acquired 218 shares of Phantom Stock (Derivative)
  Date: 2026-04-01 | Code: A | equity_swap_involved: false | shares_owned_after: 1,432.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F2, F3

Footnotes:

• F1: Each unit of phantom stock is the economic equivalent of one share of Company common stock. Units of phantom stock become payable, in cash, consistent with the Reporting Person's distribution election made at the time of deferral.
• F2: Includes 3.57 units of phantom stock acquired in connection with the payment of a dividend on March 13, 2026 at $37.18 per share.
• F3: By Trustee, CSX Corporation Executive Deferred Compensation Plan.